U.S. Markets closed

Stryker Corp (SYK) Files 10-K for the Fiscal Year Ended on December 31, 2018

- By insider

Stryker Corp (SYK) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Stryker Corp is engaged in designing, manufacturing and marketing of medical equipment, instruments, and implantable devices. Its products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices. Stryker Corp has a market cap of $67.19 billion; its shares were traded at around $179.56 with a P/E ratio of 19.23 and P/S ratio of 5.01. The dividend yield of Stryker Corp stocks is 1.08%. Stryker Corp had annual average EBITDA growth of 6.20% over the past ten years. GuruFocus rated Stryker Corp the business predictability rank of 4.5-star.


For the last quarter Stryker Corp reported a revenue of $3.8 billion, compared with the revenue of $3.5 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $13.6 billion, an increase of 9.3% from last year. For the last five years Stryker Corp had an average revenue growth rate of 8.8% a year.

The reported diluted earnings per share was $9.34 for the year, an increase of 248.5% from previous year. Over the last five years Stryker Corp had an EPS growth rate of 27.7% a year. The Stryker Corp had a decent operating margin of 18.82%, compared with the operating margin of 19.79% a year before. The 10-year historical median operating margin of Stryker Corp is 21.02%. The profitability rank of the company is 8 (out of 10).

At the end of the fiscal year, Stryker Corp has the cash and cash equivalents of $3.6 billion, compared with $2.5 billion in the previous year. The long term debt was $8.5 billion, compared with $6.6 billion in the previous year. Stryker Corp has a financial strength rank of 5 (out of 10).

At the current stock price of $179.56, Stryker Corp is traded at 49.9% premium to its historical median P/S valuation band of $119.81. The P/S ratio of the stock is 5.01, while the historical median P/S ratio is 3.35. The intrinsic value of the stock is $104.49 a share, according to GuruFocus DCF Calculator. The stock gained 18.48% during the past 12 months.

Directors and Officers Recent Trades:

  • Director Roch Doliveux bought 46 shares of SYK stock on 01/31/2019 at the average price of $177.26. The price of the stock has increased by 1.3% since.
  • VP, Chief HR Officer M Kathryn Fink sold 180 shares of SYK stock on 02/04/2019 at the average price of $176.77. The price of the stock has increased by 1.58% since.
  • Director Louise Francesconi sold 9,477 shares of SYK stock on 01/31/2019 at the average price of $177.2. The price of the stock has increased by 1.33% since.
  • President and COO Timothy J Scannell sold 5,282 shares of SYK stock on 01/16/2019 at the average price of $163.5. The price of the stock has increased by 9.82% since.

For the complete 20-year historical financial data of SYK, click here.

This article first appeared on GuruFocus.